| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
9,074 |
7,296 |
$438K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
6,851 |
5,684 |
$113K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,216 |
2,987 |
$85K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,644 |
1,225 |
$84K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,135 |
3,207 |
$42K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
320 |
192 |
$10K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
120 |
106 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
18 |
17 |
$476.78 |